Okay so ive browsed a bit and found some reading for you. Id say along with good monitoring on your bloods and bp etc on your log, trt+ or 250 would be preferable til you know your results from gene testing.
@LevButlerov @HarleyGuy You guys might enjoy these for some light reading. The first one though admits the study cohort is small and some findings were from individual cases but interesting non the less.
Anabolic–Androgenic Steroids Induced Cardiomyopathy: A Narrative Review of the Literature
"Chronic supraphysiologic AAS use promotes cardiac injury and adverse cardiac remodeling via oxidative stress, androgen receptor overactivation, RAAS dysregulation, and pro-apoptotic signaling. These changes could lead to hypertension, dyslipidemia and atherosclerosis, myocardial fibrosis and hypertrophy, arrhythmias, heart failure, and kidney injury. Vascular dysfunction, increased arterial stiffness, and a prothrombotic state further compound the cardiovascular risks."
"Although cessation of AAS use may lead to partial or complete reversal of cardiac dysfunction in some individuals, others may experience irreversible myocardial damage. The reversibility appears to depend on dosage, duration of exposure, and early intervention."
https://pmc.ncbi.nlm.nih.gov/articles/PMC12467473
Testosterone replacement therapy in heart failure: A systematic review of randomized controlled trials - couldnt get the free text, apparently springer studies are harder to get
"Our search yielded 653 records, of which 12 studies met the inclusion criteria. Key findings include significant improvements in muscle strength and aerobic capacity as well as increases in lean muscle mass and decreases in fat mass in certain trials. Additionally, improvements in insulin sensitivity and shortening of the QT interval were reported. TRT did not consistently affect blood pressure, lipid profiles, or heart rate, nor did it lead to any serious adverse effects."
https://link.springer.com/article/10.1007/s42000-025-00658-y
Anabolic androgenic steroids and cardiomyopathy: an update
This one mentions that Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE (TRAVERSE) study
@LevButlerov mentioned.
View attachment 243589
"Supraphysiological doses of AAS have been shown to induce cardiomyopathy via biventricular dysfunction"
https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1214374